| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |